Founder & Scientific Director
Johannes is a Assistant Professor of Psychology and Public Affairs and Affiliated Faculty in the Department of Economics at Princeton University. He is interested in understanding whether poverty has particular psychological and neurobiological consequences, and whether these consequences, in turn, affect economic behavior. His research combines laboratory experiments with randomized controlled trials of development programs. Johannes has a BA in Psychology, Physiology and Philosophy from Oxford, a PhD in Neurobiology from Harvard, a PhD in Economics from Zurich, and was previously a Prize Fellow in Economics at Harvard and a Postdoctoral Fellow at the Jameel Poverty Action Lab at MIT.
Jeremy obtained his PhD in Economics at MIT where he focused his research on development economics and behavioral economics. He then worked as a Post Doctoral Associate at Yale University, continuing to research development economics and aid effectiveness in India, the Philippines, South Africa, Mexico, Kenya, and Peru. Jeremy was a co-founder and director of GiveDirectly from 2009-2012, and brings a wide range of consulting experiences from his time at McKinsey & Company.
Associate Scientific Director
Chaning is a post doctoral research associate at Princeton University. He is interested in the intersections of psychology, behavioral economics and development. Chaning’s current work includes an RCT on savings mechanisms and work on the effect of stress on decision making. Previously, Chaning was an English teacher in the Czech Republic, a futures trader in Los Angeles. He has a PhD in economics from the University of Hawaii.
James is responsible for overseeing the long term development goals of the center, as well as ensuring the smooth operation of our existing systems. James has managed behavioral field and lab projects in Kenya, Peru, Indonesia, Pakistan, and Sierra Leone and has worked as a consultant for the World Bank and a Project Coordinator for Innovations for Poverty Action (IPA). James joined Busara in 2012 after managing a randomized control trial for IPA based out of Busia, Kenya.